Fairfield Financial Advisors, LTD Charles River Laboratories International, Inc. Transaction History
Fairfield Financial Advisors, LTD
- $294 Billion
- Q3 2024
A detailed history of Fairfield Financial Advisors, LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 432 shares of CRL stock, worth $80,632. This represents 0.03% of its overall portfolio holdings.
Number of Shares
432
Previous 592
27.03%
Holding current value
$80,632
Previous $122 Million
30.42%
% of portfolio
0.03%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$950 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$698 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$398 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$362 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...